Upgrade to SI Premium - Free Trial

Sernova Corp Common Shares (SEOVF)

0.09 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Seraxis names ex-FDA officer as CMO ahead of Sernova merger October 19, 2026 7:00 AM - StreetInsider Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics October 19, 2026 7:00 AM - Globe NewsWire Sernova and Seraxis close $11.2M financing ahead of merger October 5, 2026 7:00 AM - StreetInsider Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial October 5, 2026 7:00 AM - Globe NewsWire Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference September 25, 2026 7:00 AM - Globe NewsWire Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference September 10, 2026 7:00 AM - Globe NewsWire Sernova and Seraxis agree to merge, forming BetaNova Biosciences September 8, 2026 7:01 AM - StreetInsider Full Article List